Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis.
Wei B et al. Onco Targets Ther. 2016 Jul 1;9:4015-22. doi: 10.2147/OTT.S102733. eCollection 2016.
RGS1 expression is associated with poor prognosis in multiple myeloma.
Roh J et al. J Clin Pathol. 2016 Jul 21. pii: jclinpath-2016-203713. doi: 10.1136/jclinpath-2016-203713. [Epub ahead of print].
Diagnostic performances of M-protein tests according to the clinical presentations of kidney disease.
Koo EH et al. Eur J Intern Med. 2016 Jul 12. pii: S0953-6205(16)30197-2. doi: 10.1016/j.ejim.2016.06.028. [Epub ahead of print].
Prediction of presence of kidney disease in patients undergoing intravenous iodinated contrast enhanced computed tomography: a validation study.
Schreuder SM et al. Eur Radiol. 2016 Jul 19. [Epub ahead of print].
Anaplastic Variant of Plasma Cell Myeloma: A Pitfall of Morphlogical Identification.
Beljan Perak R et al. Acta Cytol. 2016 Jul 19. [Epub ahead of print].
Polychromatic flow cytometry is more sensitive than microscopy in detecting small monoclonal plasma cell populations.
Tran DN et al. Cytometry B Clin Cytom. 2016 Jul 14. doi: 10.1002/cyto.b.21401. [Epub ahead of print].
Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib.
Kasamatsu T et al. Hematol Oncol. 2016 Jul 13. doi: 10.1002/hon.2322. [Epub ahead of print].
Single-Tube 10-Fluorochrome Analysis for Efficient Flow Cytometric Evaluation of Minimal Residual Disease in Plasma Cell Myeloma.
Royston DJ et al. Am J Clin Pathol. 2016 Jul;146(1):41-9. doi: 10.1093/ajcp/aqw052.
Baseline bone involvement in multiple myeloma – a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients.
Hinge M et al. Haematologica. 2016 Jul 6. pii: haematol.2016.146092. [Epub ahead of print].
Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.
Chakraborty R et al. Leuk Lymphoma. 2016 Jul 7:1-8. [Epub ahead of print].
Plasma cell maturity as a predictor of prognosis in multiple myeloma.
Iriyama N et al. Med Oncol. 2016 Aug;33(8):87. doi: 10.1007/s12032-016-0803-3. Epub 2016 Jul 6.
Correlation of multiparameter flow cytometry and bone marrow trephine immunohistochemistry in the identification and characterization of neoplastic plasma cells.
Menter T et al. Br J Haematol. 2016 Jul 5. doi: 10.1111/bjh.14223. [Epub ahead of print].
Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression.
Gonsalves WI et al. Leukemia. 2016 Jul 26. doi: 10.1038/leu.2016.205. [Epub ahead of print].